Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery

NCT03519165 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DEVICE: EV1000(FloTrac System 4.0)

Sponsor

Tata Medical Center